Live feed
Filing
SC 13D
SC 13D0001193125-15-004983·Shanxi Taxus Pharmaceuticals Co., Ltd.
Schedule 13D ownership disclosure
CASMYN CORP
Security class unavailable
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 27.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-004983
- Form type
- SC 13D
- Filer
- Shanxi Taxus Pharmaceuticals Co., Ltd.
- CIK
- CIK 1617864
- Filed
- Jan 08, 2015
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership